NCT01206907View on ClinicalTrials.gov

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Chronic Pain
Interventions
DRUG

oxymorphone IR

oxymorphone IR liquid

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY